Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00526994 · ClinicalTrials.gov registry record · Phase 2
Randomized Controlled Trial of Routine Screening for IPV
A Phase 2 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 2
- Development phase
- 2,700
- Enrollment target
NCT00526994: Completed Phase 2 study, sponsored by Centers for Disease Control and Prevention.
NCT00526994 is a Phase 2 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 2,700 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1930% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00526994, a Phase 2 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,700 participants
- Enrollment target
Study Summary
This is a randomized controlled trial with three arms to establish the impact of screening and referral to services for women disclosing exposure to IPV.
Primary Outcome
Assessed with Quality of Life SF-12 V.2 (Ware, Kosinski,Turner-Bowker, \& Gandek, 2002). This instrument has 12 items measuring eight subscales of mental and physical health-general health, physical functioning, role limitations due to physical health problems, role limitations due to emotional problems, bodily pain, vitality (energy/fatigue), social functioning, and mental health (psychological distress)-during the past 4 weeks. These subscales are combined to form a physical health composite s
Interventions
- OTHER screened
- BEHAVIORAL universal education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,700 participants |
| Start Date | 2008-05 |
| Est. Completion | 2011-06 |
| Phase | Phase 2 |
What the finished NCT00526994 record still lists
NCT00526994 is an interventional study that assigns participants to a tested intervention. Its 2,700 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1930% higher).
The record links to 0 conditions, and to 2 interventions - of which screened is the first listed.
NCT00526994 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00526994 about?
NCT00526994 is a clinical study titled "Randomized Controlled Trial of Routine Screening for IPV". This is a randomized controlled trial with three arms to establish the impact of screening and referral to services for women disclosing exposure to IPV.
What is the current status of trial NCT00526994?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,700 participants. The study started on 2008-05. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00526994?
The interventions under investigation include: screened (OTHER), universal education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00526994?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00526994's enrollment target sits among peer trials
2,700 7th of 2000 higher than 1,994 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
- NCT06052267 · 2,700 participants · Phase 3
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia